U.s. Physical Therapy, Inc. · NYSE:USPH

U.s. Physical Therapy — Bank of America Conference 2023

30 slides from U.s. Physical Therapy's conference presentation, May 2023

  1. Slide 1: Investor Presentation May 2023

    Investor Presentation May 2023

  2. Slide 2: Disclaimer

    Disclaimer Forward Looking Statements This presentation contains forward-looking statements, which involve numerous risks and uncertainties. Included are statements relating to opening of new clinics, availability of personnel and reimbursement environment. The forward-looking statements are based o

  3. Slide 3: Investment Highlights

    Investment Highlights Leading Physical Therapy Company  As of March 31, 2023, operated 647 outpatient physical and occupational therapy clinics across 40 states  One of the largest PT clinic owner/operator platforms  Growing Industrial Injury Prevention business  One of two publicly-traded, pure

  4. Slide 4: Expanding National Footprint of Physical Therapy Clinics

    Expanding National Footprint of Physical Therapy Clinics WA 11 MT VT ME 2 ND 1 8 OR 2 32 ID MN MA 17 SD 6 WI 2 WY 1 7 MI 7 50 IA PA CT NV 2 29 NJ 16 OH 4 IN 11 7 8 WV DE VA 9 MO 5 47 KS 10 19 MD NC 28 TN 1 AZ OK 81 20 6 AR SC 5 15 AL GA MS 22 AK 12 LA 2 4 TX 86 11 FL 37 HI 4 HI 4 Added 93 clinics in

  5. Slide 5: Large and Growing Market Opportunity

    Large and Growing Market Opportunity  $30B+ U.S. rehab market with projected growth  Favorable demographics – physically active, aging and obese population segments  Untapped market potential  ~50% of Americans over 18 years old develop a musculoskeletal injury that lasts more than 3 months  Wi

  6. Slide 6: Setting for Physical Therapy Care

    Setting for Physical Therapy Care Within physical therapy, outpatient clinics are the leading setting for care Outpatient Clinics Hospitals; Home Offices of Other State, Local, Health Total Physicians and Private Orthopedic rehab is the primary driver of physical therapy services, representing appro

  7. Slide 7: Payors See Significant ROI for Physical Therapy

    Payors See Significant ROI for Physical Therapy With PT Without PT Hip replacement surgery Hip replacement surgery ($56,000) ($56,000) Inpatient care Inpatient care ($15,000) ($15,000) Outpatient Physical Readmission Readmission Rate of Home Rate of Therapy Clinic 10% 20% Full Recovery Full Recovery

  8. Slide 8: Competitive Landscape

    Competitive Landscape Highly fragmented U.S. outpatient rehab market with 37,000+ clinics (1) No company with >10% market share USPh is one of the largest owner/operator of PT clinics USPh is well-positioned to capitalize in a more challenged macro environment 1,900+ 900+ 647 Clinics(2) Clinics(2) C

  9. Slide 9: Growth Strategy

    Growth Strategy 1 Drive organic growth through de novo PT/OT clinic openings, utilize true partnership model 2 Maximize profits of existing facilities by growing patient volume, improving pricing, increasing efficiencies and adding programs and services 3 Augment organic growth through strategic acq

  10. Slide 10: Focused Business Model

    Focused Business Model  Specialize in trauma, sports, work-related and pre- and post-surgical cases  Partner with experienced physical therapists  Drive volume via referrals  Augment sales with marketing reps  Organic growth includes lower cost de novo start up clinics  Strategic acquisitions

  11. Slide 11: USPh Partnership Advantages

    USPh Partnership Advantages Accounting Capital and Resources to Enhance Development Rate HR Less Personal Financial Real Estate Risk Construction Aligned Practice Incentives Purchasing Unlimited Earnings Potential Marketing Enhanced Benefits Compliance Package Legal Business Intelligence and Collabo

  12. Slide 12: Acquisition Strategy

    Acquisition Strategy Completed 47 acquisitions since 2005 ranging in size from 3 to 52 clinics Acquisitions include five industrial injury prevention services businesses Seeking & evaluating M&A transactions is part of USPh’s DNA Acquisition criteria: Owner therapists continue to operate clinics and

  13. Slide 13: New Clinics / Brands Since January 2022

    New Clinics / Brands Since January 2022 From 1/1/2022 – 3/31/2023 2 4 2 14 WA ME MT ND OR VT MN ID SD WI MA 7 MI CT WY IA PA NJ NV OH MD IN DE WV MO VA KS 6 NC TN AZ 5 OK AR SC 6 AL GA MS TX LA FL AK HI 2 15 56 clinics added since January 1, 2022 13

  14. Slide 14: Scale Advantages Create a Robust Business Case for Consolidation

    Scale Advantages Create a Robust Business Case for Consolidation Referrals Payor Networks Higher likelihood of referrer Increased likelihood of selection for activity and advocacy payor networks ▪ Scale is cited as a core criterion by specialty network managers and payors. ▪ Some limited leverage in

  15. Slide 15: Revenue Mix by Segment and Payor Type

    Revenue Mix by Segment and Payor Type Revenue Mix by Segment Type Physical Therapy Revenue Mix by Payor Type Quarter Ended March 31, 2023 Quarter Ended March 31, 2023 6% 13% 9% 48% 33% 87% 4% Private Insurance & Managed Care Physical Therapy Operations Medicaid Industrial Injury Prevention Medicare

  16. Slide 16: USPh Physical Therapy Growth Drivers

    USPh Physical Therapy Growth Drivers Both prior to and post COVID-19, each driver has shown robust growth Number of Clinics (1) Daily Patient Visits Per Clinic 2012-1Q23: CAGR +4.0% 2012-1Q23: CAGR +3.1% 700 640 647 35 578 591 583 554 591 29.1 28.7 29.8 600 540 30 27.6 24.6 508 25 25.9 26.6 472 489

  17. Slide 17: Daily Volumes Progression

    Daily Volumes Progression Average Visits per Clinic per Day COVID Trough 35 30.0 29.5 29.8 29.5 29.1 29.8 30 27.9 28.8 27.7 27.1 26.2 25.8 25 20 18.9 15 10 5 0 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23  First Quarter 2023 average daily visits per clinic were a record-high for

  18. Slide 18: Physical Therapy Operations

    Physical Therapy Operations Annual Gross Margin Percentage Quarterly Gross Margin Percentage 26.0% 26.0% 23.6% 23.8% 24.0% 24.0% 23.1% 22.7% 22.0% 22.0% 22.0% 21.0% 20.2% 20.0% 20.0% 20.0% 20.0% 18.7% 18.0% 18.0% 16.0% 16.0% 14.0% 14.0% 12.0% 12.0% 2018 2019 2020 2021 2022 Q1 2022 Q2 2022 Q3 2022 Q4

  19. Slide 19: Industrial Injury Prevention

    Industrial Injury Prevention Industrial Injury Prevention services include industrial sports medicine and injury prevention; post offer testing; ergonomic services; occupational health and medical services; specialized solutions Since USPh’s initial entry into the Industrial Injury Prevention servic

  20. Slide 20: Industrial Injury Prevention

    Industrial Injury Prevention Revenue ($ in millions) Margin Percentage (%) $90.0 30.0% $80.0 $77.1 25.7% 25.0% 24.4% $70.0 22.4% 20.4% 20.7% $60.0 20.0% $50.0 $43.9 15.0% $39.2 13.3% $40.0 $37.5 $30.0 $25.5 10.0% $20.0 5.0% $10.0 $4.9 $0.0 0.0% 2017 2018 2019 2020 2021 2022 2017 2018 2019 2020 2021

  21. Slide 21: Strong Cash Flow and Balance Sheet

    Strong Cash Flow and Balance Sheet Adjusted EBITDA(1) ($ in millions) Liquidity ($ in millions) (as of 3/31/23) Highest Q1 Adj. ~6% Growth EBITDA in Even with Year $169.6 Company Over Year History $18.5 Inflation Effects $137.0 $17.5 $32.6 1Q22 1Q23 Liquidity Adj EBITDA Cash Revolver Capacity Strong

  22. Slide 22: Strong Return to Shareholders

    Strong Return to Shareholders USPh Share Price (9/30/2003 – 5/5/2023) $120.00 $114.10  CEO joined Company in Fall of 2003 $100.00 $80.00  Total Cumulative Return through May 5, 2023 $60.00 including dividends is $111.84 $40.00 $20.00 $12.21  Cumulative Total Shareholder Return Percentage is 916.0

  23. Slide 23: Executive Management

    Executive Management ▪ Joined USPh as COO in November 2003 Chris Reading ▪ Promoted to CEO and Board in November 2004 Chief Executive ▪ Previously Senior Vice President of Operations with HealthSouth, managed over 200 facilities including OP, Officer ASC, DX Imaging and rehab hospital operations ▪ B

  24. Slide 24: Summary

    Summary Publicly-traded, pure play operator of rehab clinics Proven business model, driven by organic growth and acquisitions Significant scale with national footprint Large and growing market / favorable demographics Strong cash flow and balance sheet Attractive Dividend Yield 24

  25. Slide 25: Appendix

    ~ APPENDIX > a ONE PARTNER : al Bi ‘Vis

  26. Slide 26: First Quarter 2023 and 2022 Results

    First Quarter 2023 and 2022 Results First Quarter Ended March 31, 2023 2022 (in thousands, except per share data) Net Revenue $ 148,509 $ 131,704 Gross profit 30,857 26,588 Operating income 16,998 15,032 GAAP Net income 11,427 11,982 Net Income attributable to USPH shareholders 7,410 8,799 Earnings

  27. Slide 27: Segment Information – First Quarter 2023 and 2022 Results

    Segment Information – First Quarter 2023 and 2022 Results First Quarter Ended March 31, 2023 2022 (in thousands, except percentages) Gross profit $ 30,857 $ 26,588 PT Gross profit $ 26,759 $ 22,041 PT Gross margin % 21.0% 20.0% Industrial injury prevention gross profit $ 3,768 $ 4,152 Industrial inj

  28. Slide 28: Reconciliation of Non-GAAP Financial Measures – Operating Results

    Reconciliation of Non-GAAP Financial Measures – Operating Results Three Months Ended March 31, Earnings per share 2023 2022 Computation of earnings per share - USPH shareholders: Net income attributable to USPH shareholders $ 7,410 $ 8,799 Charges to retained earnings: Revaluation of redeemable non-

  29. Slide 29: Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA

    Reconciliation of Non-GAAP Financial Measures – Adjusted EBITDA Three Months Ended March 31, 2023 2022 Adjusted EBITDA Net income attributable to USPH shareholders $ 7,410 $ 8,799 Adjustments: Depreciation and amortization 3,788 3,824 Change in fair value of contingent earn-out consideration 698 - I

  30. Slide 30: Thank you

    USP ONE PARTNER Thank you

U.S. Physical Therapy — Bank of America Conference 2023 on 6ix